Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Myriam Ben Arush"'
Autor:
Neta Nevo, Tsila Zuckerman, Shiri Gur-Cohen, Orit Kollet, Francesca Avemaria, Elizabeth J. Shpall, Mayela C. Mendt, Arnon Nagler, Benjamin Brenner, Myriam Ben Arush, Tsvee Lapidot
Publikováno v:
HemaSphere, Vol 3, Iss 5 (2019)
Externí odkaz:
https://doaj.org/article/dcb5ff6428b844599f31440203785f77
Autor:
Gianni Bisogno, Veronique Minard-Colin, Ilaria Zanetti, Andrea Ferrari, Soledad Gallego, Raquel Dávila Fajardo, Henry Mandeville, Anna Kelsey, Rita Alaggio, Daniel Orbach, Sheila Terwisscha van Scheltinga, Gabriela Guillén Burrieza, Myriam Ben-Arush, Heidi Glosli, Peter Mudry, Sima Ferman, Christine Devalck, Anne Sophie Defachelles, Johannes Hendrikus Maria Merks, Meriel Jenney
Publikováno v:
Journal of Clinical Oncology. 41:2342-2349
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Tr
Autor:
Reineke A. Schoot, Julia C. Chisholm, Michela Casanova, Veronique Minard-Colin, Birgit Geoerger, Alison L. Cameron, Beatrice Coppadoro, Ilaria Zanetti, Daniel Orbach, Anna Kelsey, Timothy Rogers, Cecile Guizani, Markus Elze, Myriam Ben-Arush, Kieran McHugh, Rick R. van Rijn, Sima Ferman, Soledad Gallego, Andrea Ferrari, Meriel Jenney, Gianni Bisogno, Johannes H.M. Merks
Publikováno v:
Scientia
Journal of clinical oncology, 19(32):JCO.21.02981, 3730-3740. American Society of Clinical Oncology
Journal of clinical oncology, 19(32):JCO.21.02981, 3730-3740. American Society of Clinical Oncology
PURPOSE Outcome for patients with metastatic rhabdomyosarcoma (RMS) is poor. This study presents the results of the MTS 2008 study with a pooled analysis including patients from the concurrent BERNIE study. PATIENTS AND METHODS In MTS 2008, patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba487c58a9b7c2c5a505d6da4056f724
https://hdl.handle.net/11351/8544
https://hdl.handle.net/11351/8544
Autor:
Andrea Ferrari, Julia C Chisholm, Meriel Jenney, Veronique Minard-Colin, Daniel Orbach, Michela Casanova, Gabriela Guillen, Heidi Glosli, Rick R van Rijn, Reineke A Schoot, Alison L Cameron, Timothy Rogers, Rita Alaggio, Myriam Ben-Arush, Henry C Mandeville, Christine Devalck, Anne-Sophie Defachelles, Beatrice Coppadoro, Gianni Bisogno, Johannes H M Merks
Publikováno v:
Ferrari, A, Chisholm, J C, Jenney, M, Minard-Colin, V, Orbach, D, Casanova, M, Guillen, G, Glosli, H, van Rijn, R R, Schoot, R A, Cameron, A L, Rogers, T, Alaggio, R, Ben-Arush, M, Mandeville, H C, Devalck, C, Defachelles, A-S, Coppadoro, B, Bisogno, G & Merks, J H M 2022, ' Adolescents and young adults with rhabdomyosarcoma treated in the European paediatric Soft tissue sarcoma Study Group (EpSSG) protocols : a cohort study ', The Lancet Child and Adolescent Health, vol. 6, no. 8, pp. 545-554 . https://doi.org/10.1016/S2352-4642(22)00121-3
The Lancet Child and Adolescent Health, 6(8), 545-554. Elsevier BV
The Lancet Child and Adolescent Health, 6(8), 545-554. Elsevier BV
Background: Adolescent and young adult patients with rhabdomyosarcoma often have poorer outcomes than do children. We aimed to compare the findings of adolescent and young adult patients with children enrolled in two prospective clinical protocols. M
Autor:
Myriam Ben-Arush, Veronique Minard-Colin, Giovanni Scarzello, Raquel D. Fajardo, Sheila Terwisscha Van Scheltinga, Valérie Bernier, Meriel Jenney, Soledad Gallego, Ilaria Zanetti, Maja Cesen, Johannes H.M. Merks, Gianni Bisogno
Regional lymph node disease (N1) is a component of the risk-based treatment stratification in rhabdomyosarcoma (RMS). The purpose of this study was to determine the contribution of nodal disease to the prognosis of patients with non-metastatic embryo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02eb2f1132e2273949518348eab57702
https://hdl.handle.net/11577/3472430
https://hdl.handle.net/11577/3472430
Autor:
Irina Zaidman, Hadhud Mohamad, Lidor Shalom, Myriam Ben Arush, Ehud Even‐Or, Dina Averbuch, Amir Zilkha, Jacques Braun, Asaf Mandel, David Kleid, Ori Attias, Josef Ben‐Ari, Rebecca Brooks, Aharon Gefen, Polina Stepensky
Publikováno v:
Pediatric Blood & Cancer. 69
Although hematopoietic stem cell transplantation (HSCT) is the only curative option for some children with malignant and nonmalignant disorders, the procedure itself carries a high risk of complications. A proportion of children undergoing HSCT devel
Autor:
Shourouk Ghanem, Mifleh Tatour, Yonatan Crispel, Haim Cohen, Yona Nadir, Inna Kogan, Neta Nevo, Myriam Ben-Arush
Publikováno v:
The American Journal of Pathology. 189:1654-1663
Metastasis most commonly occurs in the liver, lung, bone, and brain, implying its preference for specific organs. We hypothesized that organ microcirculation coagulation environment predisposes to tumor cell retention. Coagulation factors were analyz
Autor:
Josephin Issakov, Amit Dotan, A. Nirkin, Myriam Ben-Arush, Yehuda Kollender, Isaac Meller, Gideon Flusser, Ian J. Cohen, Y. Neumann, Shlomo Dadia, Jacob Bickels
Publikováno v:
Journal of Children's Orthopaedics. 4:391-400
Purpose Most children today with bone sarcomas undergo limb-sparing surgery. When treating children younger than 12 years of age, the result is significant limb length discrepancy (LLD). One of the solutions is the use of an expandable endoprosthesis
Publikováno v:
Human Reproduction; Oct2007, Vol. 22 Issue 10, p2799-2799, 1p